DOMAIN THERAPEUTICS
Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.
DOMAIN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Illkirch, Alsace, France
Country:
France
Website Url:
http://www.domaintherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+33 3 90 40 61 50
Email Addresses:
[email protected]
Total Funding:
89.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Omnes Capital
Omnes Capital investment in Series A - Domain Therapeutics
Seventure Partners
Seventure Partners investment in Series A - Domain Therapeutics
Theodorus III
Theodorus III investment in Series A - Domain Therapeutics
3B Future Health Fund
3B Future Health Fund investment in Series A - Domain Therapeutics
Viva BioInnovator
Viva BioInnovator investment in Series A - Domain Therapeutics
Turenne Capital
Turenne Capital investment in Series A - Domain Therapeutics
adMare Bio Innovations
adMare Bio Innovations investment in Series A - Domain Therapeutics
Panacea Venture
Panacea Venture investment in Series A - Domain Therapeutics
Schroders Capital
Schroders Capital investment in Series A - Domain Therapeutics
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series A - Domain Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-09-12 | Ermium Therapeutics | Domain Therapeutics investment in Series A - Ermium Therapeutics | 6.3 M EUR |
| 2016-10-18 | Mavalon Therapeutics | Domain Therapeutics investment in Seed Round - Mavalon Therapeutics | 9 M EUR |
Official Site Inspections
http://www.domaintherapeutics.com Semrush global rank: 3.76 M Semrush visits lastest month: 3.58 K
- Host name: cluster002.hosting.cdn.ovh.net
- IP address: 46.105.204.2
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
